Literature DB >> 31647546

Functional Human CD141+ Dendritic Cells in Human Immune System Mice.

Jordana G A Coelho-Dos-Reis1,2, Ryota Funakoshi1, Jing Huang1, Felipe Valença Pereira1,3, Sho Iketani1,4, Moriya Tsuji1.   

Abstract

BACKGROUND: For the purpose of studying functional human dendritic cells (DCs) in a humanized mouse model that mimics the human immune system (HIS), a model referred to as HIS mice was established.
METHODS: Human immune system mice were made by engrafting NOD/SCID/IL2Rgammanull (NSG) mice with human hematopoietic stem cells (HSCs) following the transduction of genes encoding human cytokines and human leukocyte antigen (HLA)-A2.1 by adeno-associated virus serotype 9 (AAV9) vectors.
RESULTS: Our results indicate that human DC subsets, such as CD141+CD11c+ and CD1c+CD11c+ myeloid DCs, distribute throughout several organs in HIS mice including blood, bone marrow, spleen, and draining lymph nodes. The CD141+CD11c+ and CD1c+CD11c+ human DCs isolated from HIS mice immunized with adenoviruses expressing malaria/human immunodeficiency virus (HIV) epitopes were able to induce the proliferation of malaria/HIV epitopes-specific human CD8+ T cells in vitro. Upregulation of CD1c was also observed in human CD141+ DCs 1 day after immunization with the adenovirus-based vaccines.
CONCLUSIONS: Establishment of such a humanized mouse model that mounts functional human DCs enables preclinical assessment of the immunogenicity of human vaccines in vivo.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD141; CD1c; adenovirus vaccine; human dendritic cells; human immune system mice

Mesh:

Substances:

Year:  2020        PMID: 31647546      PMCID: PMC7457331          DOI: 10.1093/infdis/jiz432

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood.

Authors:  A Dzionek; A Fuchs; P Schmidt; S Cremer; M Zysk; S Miltenyi; D W Buck; J Schmitz
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

2.  CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions.

Authors:  Lars Ohl; Mariette Mohaupt; Niklas Czeloth; Gabriele Hintzen; Ziba Kiafard; Jörg Zwirner; Thomas Blankenstein; Golo Henning; Reinhold Förster
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

Review 3.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

Review 4.  The CD8+ dendritic cell subset.

Authors:  Ken Shortman; William R Heath
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

5.  Generation of Humanized Mice for Analysis of Human Dendritic Cells.

Authors:  Yasuyuki Saito; Jana M Ellegast; Markus G Manz
Journal:  Methods Mol Biol       Date:  2016

Review 6.  Adeno-associated virus vectors for gene therapy.

Authors:  T R Flotte; B J Carter
Journal:  Gene Ther       Date:  1995-08       Impact factor: 5.250

Review 7.  CCR7 and its ligands: balancing immunity and tolerance.

Authors:  Reinhold Förster; Ana Clara Davalos-Misslitz; Antal Rot
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

8.  Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines.

Authors:  Chun I Yu; Christian Becker; Patrick Metang; Florentina Marches; Yuanyuan Wang; Hori Toshiyuki; Jacques Banchereau; Miriam Merad; A Karolina Palucka
Journal:  J Immunol       Date:  2014-09-22       Impact factor: 5.422

9.  Effects of mesenchymal stromal cells on human myeloid dendritic cell differentiation and maturation in a humanized mouse model.

Authors:  Ping Chen; Yanfei Huang; Karl L Womer
Journal:  J Immunol Methods       Date:  2015-10-30       Impact factor: 2.303

10.  Reconstitution of huPBL-NSG mice with donor-matched dendritic cells enables antigen-specific T-cell activation.

Authors:  Airi Harui; Sylvia M Kiertscher; Michael D Roth
Journal:  J Neuroimmune Pharmacol       Date:  2010-06-08       Impact factor: 4.147

View more
  2 in total

1.  An In Vivo Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity.

Authors:  Xuedan He; Shiqi Zhou; Breandan Quinn; Dushyant Jahagirdar; Joaquin Ortega; Mark D Long; Scott I Abrams; Jonathan F Lovell
Journal:  Cancer Immunol Res       Date:  2022-03-01       Impact factor: 12.020

2.  Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice.

Authors:  Jing Huang; Jing Zhou; Reem Ghinnagow; Toshiyuki Seki; Sho Iketani; Daphnée Soulard; Patrick Paczkowski; Yukiko Tsuji; Sean MacKay; Luis Javier Cruz; François Trottein; Moriya Tsuji
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.